-
Posted by
Two Blokes Jul 9 -
Filed in
Stock
-
5 views
I rate Xylem a buy, driven by secular water scarcity, aging infrastructure, and PFAS treatment themes that ensure durable, non-discretionary demand. XYL's 80/20 transformation is already delivering tangible margin gains, with further upside from the Evoqua integration and PFAS funding pipeline. Despite near-term softness in some segments and tariff headwinds, XYL's long-term growth is underpinned by resilient end markets and internal self-help levers.
